JPRN-UMIN000008465
Completed
N/A
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancer - PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancer
Osaka Breast Cancer Chemo-Endocrine Therapy Study Group0 sites30 target enrollmentJuly 18, 2012
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- HER2 positive resectable primary breast cancer
- Sponsor
- Osaka Breast Cancer Chemo-Endocrine Therapy Study Group
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Current history of malignant neoplasm. 2\. Bilateral invasive breast cancer. 3\. Cases who does not wish to undergo an operation after neoadjuvant chemotherapy. 4\. Patients with medical conditions that renders them intolerant to primary chemotherapy and related treatment, including infection, diarrhea, intestinal paralysis, severe Diabetes Mellitus. 5\. Has history of hypersensitivity reaction in important drug of this study. 6\. Positive for HBs antigen. 7\. 8\. With severe peripheral neuropathy. 9\. Transfusion within the past 2 weeks. 10\. With the history of severe mental disease or under treatment. 11\. With active pleural effusion or ascites. 12\. Pregnancy, or suspected pregnancy. 13\. Cases who physician judged improper to entry this trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerpancreatic cancerC535836JPRN-jRCT1041230068Ebata Tomoki50
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intakeesophageal cancerJPRN-UMIN000017153Second Department of Surgery, Wakayama Medical University40
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with nab-paclitaxel followed by FEC in patitents with operable breast cancerbreast cancerJPRN-UMIN000030692kyushu Breast Cancer Study Group40
Completed
Phase 2
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancerStage III gastric cancerJPRN-UMIN000001584Department of Surgery Graduate School of Medicine, Kyoto University49
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30